Seminars in Pediatric Surgery
Volume 16, Issue 3 , Pages 172-177 , August 2007

Surgical management of upper gastrointestinal and small bowel Crohn’s disease

  • Stephen E. Dolgin, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Stephen E. Dolgin, MD, Pediatric Surgery, Schneider Children’s Hospital, Room 158, 269-01 76th Avenue, New Hyde Park, NY 11040.

References 

  1. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. J Am Med Assoc. 1932;99:1323–1329
  2. Aufses AH. The history of Crohn’s disease. Surg Clin North Am. 2001;81:1–11
  3. Reynolds HL, Stellato TA. Crohn’s disease of the foregut. Surg Clin North Am. 2001;81:117–135
  4. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn’s disease. J Pediatr Gastrointest Nutr. 1994;19:181–186
  5. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics. 1989;83:777–781
  6. Mashako MNL, Cezard JP, Navarro J, et al. Crohn’s disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastrointest Nutr. 1989;8:442–446
  7. Griffiths AM, Alemayehu E, Sherman P. Clinical features of gastroduodenal Crohn’s disease in adolescents. J Pediatr Gastrointest Nutr. 1989;8:166–171
  8. Yamamoto T, Bain IM, Connolly AB, et al. Outcome of strictureplasty for duodenal Crohn’s disease. Br J Surg. 1999;86:259–262
  9. Worsey MJ, Hull T, Ryland L, et al. Strictureplasty is an effective option in the operative management of duodenal Crohn’s disease. Dis Colon Rectum. 1999;42:596–600
  10. Telander RL, Schmeling DJ. Current surgical management of Crohn’s disease in childhood. Semin Pediatr Surg. 1994;3:19–27
  11. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988;29:588–592
  12. Sawczenko A, Ballinger AB, Savage MO, et al. Clinical features affecting final height in patients with pediatric-onset Crohn’s disease. Pediatrics. 2006;118:124–129
  13. Fazio VW, Marchetti F, Church JM. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel A randomized controlled trial. Ann Surg. 1996;224:563–573
  14. Fazio VW, Aufses HA. Evolution of surgery for Crohn’s disease. Dis Colon Rectum. 1999;42:970–988
  15. Corman ML. Crohn’s disease and indeterminate colitis. In:  Corman ML editors. Colon and Rectal Surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;
  16. Maartense S, Dunker MS, Slors JF, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial. Ann Surg. 2006;243:143–149
  17. Lowney JK, Dietz DW, Birnbaum EH, et al. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn’s disease compared with conventional surgery? (A long-term follow-up study). Dis Colon Rectum. 2006;49:58–63
  18. Bonnard A, Fouquet V, Berrebi D, et al. Crohn’s disease in children (Preliminary experience with a laparoscopic approach). Eur J Pediatr Surg. 2006;16:90–93
  19. Markowitz J, Markowitz JE, Bousvaros A, et al. Workshop report: Prevention of postoperative recurrence in Crohn’s disease. J Pediatr Gastrointest Nutr. 2005;41:145–151
  20. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963
  21. Olaison G, Smedh K, Sjodah R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualized ileal ulcers preceeding symptoms. Gut. 1992;33:331–335
  22. Baldassano RN, Han PD, Jeshion WC, et al. Pediatric Crohn’s disease: risk factors for postoperative recurrence. Am J Gastoenterol. 2001;96:2169–2176
  23. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative Maintenance of Crohn’s disease remission with 6-Mercaptopurine, Mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723–729

PII: S1055-8586(07)00024-8

doi: 10.1053/j.sempedsurg.2007.04.004

Seminars in Pediatric Surgery
Volume 16, Issue 3 , Pages 172-177 , August 2007

Article Tools

* Image Usage & Resolution